Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Triple Negative Breast Neoplasms × CP protocol × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcopenia 1 Ovarian Neoplasms 1 Malnutrition 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Dysgeusia 1

Interventions

camrelizumab 2 Injections 2 toripalimab 1 epigallocatechin gallate 1 atezolizumab 1 Zinc 1 Tablets 1 Quercetin 1 Nivolumab 1 Metformin 1 Imatinib Mesylate 1 Gemcitabine 1 Everolimus 1 Epirubicin 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03168880 2025-04-09

TNBC

Tata Memorial Hospital

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡